Dr. Erkut Borazanci joins the SegueTx team
Jared Snider
We are proud to announce that Erkut Borazanci, M.D. has agreed to become the first clinical science advisor at the company. He was trained at LSUHSC-S where he received a Master's Degree in Biochemistry and Molecular Biology and an M.D. He is a practicing oncologist at HonorHealth in Scottsdale, Arizona and has been a principal investigator on 26 clinical trials. Data from a recent Phase I trial suggests that combination therapy could be efficacious against pancreatic cancer, a devastating disease that claims the lives of 40,000 Americans every year.